Evidence map›Paper›PMID 29441102›Full record

ArticleJournal of contemporary brachytherapy2017

Dosimetric analysis of rib interference of the CTV during interstitial brachytherapy of lung tumors.

Bo Yang, Xiaoyang Sun, Haowen Pang, Xiangxiang Shi, Tao Tang, Guangpeng Zhang, Renjin Chen, Jing Zhang, Hong Wu, Sheng Lin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of contemporary brachytherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Template-assistedJournal of contemporary brachytherapy · 2019
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Bo YangDepartment of Radiotherapy.
Xiaoyang SunDepartment of Radiotherapy.
Haowen PangDepartment of Radiotherapy.
Xiangxiang ShiDepartment of Radiotherapy.
Tao TangDepartment of Radiotherapy.
Guangpeng ZhangDepartment of Radiotherapy.
Renjin ChenDepartment of Radiotherapy.
Jing ZhangDepartment of Radiotherapy.
Hong WuDepartment of Radiotherapy.
Sheng LinDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Qinglian WenDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yunwei HanDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Jingbo WuDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Affiliated Hospital of Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn interstitial brachytherapy for lung tumors, the placement and alignment of the source needles are influenced by the ribs, which can affect the dose distribution. This study evaluated the change in dose to the target by comparing the dose between the actual interstitial brachytherapy plan (AIBP, what is deliverable due to anatomic constraints), and the virtual interstitial brachytherapy plan (VIBP, pretreatment-modified dose distribution). MATERIAL AND

methodsAIBPs and VIBPs were designed for 20 lung tumors. The VIBP was designed with uniform spacing between needles, regardless of the presence of ribs. The prescription dose was 30 Gy. The percentage of normal ipsilateral lung volume that received a dose ≥ 5 Gy (V

resultsThe V

conclusionsThe regular geometric alignment of needles is important for increasing the target dose and limiting the normal lung dose in interstitial brachytherapy for thoracic tumors. Thus, we recommend that radiation oncologists attempt to achieve the regular alignment of needles during implantation.

Indexed as

CTV doseinterstitial brachytherapylung cancerribs dose

Identifiers

PMID29441102
PMCPMC5807996
OpenAlexW2781495567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.